Beverly C. Handy
Department of Laboratory Medicine, Division of Pathology-Lab Medicine Div
Present Title & Affiliation
Primary Appointment
Associate Professor-Non Tenured, Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Associate Professor-Non Tenured, Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 1992 | The University of Texas Medical School Houston, Houston, TX, USA, MD, Medicine |
| 1987 | St. Mary's University, San Antonio, TX, USA, MS, Industrial Psychology |
| 1980 | United States Air Force Academy, Colorado Springs, CO, USA, BS, Behavioral Sciences |
Postgraduate Training
| 1998-1999 | Clinical Fellowship, Chemical Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 1992-1997 | Pathology Resident, The University of Texas Health Science Center, San Antonio, TX |
Board Certifications
| 1999 | Chemical Pathology, American Board of Pathology |
| 1997 | Anatomic and Clinical Pathology, American Board of Pathology |
Experience & Service
Administrative Appointments/Responsibilities
Director, Tumor Marker Laboratory, Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - Present
Program Director, Chemical Pathology Fellowship Program, Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2001 - Present
Other Appointments/Responsibilities
Chief Resident, Anatomic and Clinical Pathology Program, The University of Texas Health Science Center, San Antonio, TX, 1997 - Present
Alternate Voting Member, Instituional Review Committee Wilford Hall United States Air Force Medical Center, San Antonio, TX, 1985 - Present
Institutional Committee Activities
Member, Faculty Achievement Awards Committee, Faculty Senate, 2015 - 2017
Member, Order Set Task Force, 2013 - Present
Member, Acute and Critical Care Subcommittee, 2013 - Present
Member, Faculty Welfare Committee, Faculty Senate, 2012 - Present
Member, Physician Notification Policy Committee, 2011 - Present
Member, Quality Improvement Assessment Board, 2011 - Present
Member, Clinical Effectiveness Subcommittee, Metrics Task Force, 2010 - Present
Member, Clinical Effectiveness Subcommittee, 2008 - Present
Department Liaison, Laboratory Medicine Chair Search Committee, 2007 - Present
Member, Distinguished Alumnus Subcommittee, Alumni and Faculty Association Steering Committee, 2005 - 2016
Member, OncoLog Editorial Board, 2004 - 2016
Member, Multidisciplinary Evidence-Based Practice Review Committee, 2002 - Present
Member, Alumni and Faculty Association Steering Committee, 2002 - 2016
Member, Division of Pathology and Laboratory Medicine Steering Committee, 2002 - Present
Military or Other Governmental Service
Captain, Chief of Special Counseling, United States Air Force, 1984 - 1986
Lieutenant (second and first), Occupational Analyst, United States Air Force, 1980 - 1984
Selected Publications
Peer-Reviewed Articles
- Peacock WF, Baumann BM, Bruton D, Davis TE, Handy B, Jones CW, Hollander JE, Limkakeng AT, Mehrotra A, Than M, Ziegler A, Dinkel C.. Efficacy of High-Sensitivity Troponin T in Identifying Very-Low-Risk Patients with Possible Acute Coronary Syndrome. JAMA Cardiology, 2017. e-Pub 2017.
- Xu JY, Handy B, Michaelis CL, Waguespack SG, Hu MI, Busaidy N, Jimenez C, Cabanillas ME, Fritsche HA, Cote GJ, Sherman SI. Detection and Prognostic Significance of Circulating Tumor Cells in Patients With Metastatic Thyroid Cancer. Journal of Clinical Endocrinology & Metabolism 101(11):4461-4467, 2016. e-Pub 2016. PMID: 27575943.
- Cao L, Chen M, Phipps RA, Del Guidice RE, Handy BC, Wagar EA, Meng QH. Causes and impact of specimen rejection in a clinical chemistry laboratory. Clinica Chimica Acta 458:154-8, 2016. e-Pub 2016. PMID: 27166198.
- Meng QH, Handy BC, Wagar EA. Falsely elevated tacrolimus concentrations on the Dimension Xpand. Clinical Biochemistry 48(16-17):1210, 2015. e-Pub 2015. PMID: 26160209.
- Giuliano M, Giordano A, Jackson S, De Giorgi U, Mego M, Cohen EN, Gao H, Anfossi S, Handy BC, Ueno NT, Alvarez RH, De Placido S, Valero V, Hortobagyi GN, Reuben JM, Cristofanilli M.. Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination. Breast Cancer Research 16(5):440, 2014.
- Meng QH, Handy B, Wagar E.. A case of green blood. Clinical Chemistry 60(4):695 - 696, 2014.
- Alexanian R, Wang M, Delasalle K, Wang S, Qazilbash M, Handy B, Weber D.. Value of novel agents and intensive therapy for patients with multiple myeloma. Transplantation 49(3):422 - 425, 2014.
- Dean-Colomb W, Hess KR, Young E, Gornet TG, Handy BC, Moulder SL, Ibrahim N, Pusztai L, Booser D, Valero V, Hortobagyi GN, Esteva FJ. Elevated serum P1NP predicts development of bone metastasis and survival in early-stage breast cancer. Breast Cancer Res Treat 137(2):631 - 636, 2013. e-Pub 2012. PMID: 23242617.
Abstracts
- Handy B, Jones P, Ostlund RE Jr, Schuetz P, Schwabe A, Johannes S, Sherman J, Shapiro NI. Validation of the Elecsys BRAHMS procalcitonin assay in patients with severe sepsis or septic shock. Presented at the Society of Critical Care Medicine Annual Meeting, Honolulu, Hawaii, 2017.
- Cao L, Lee C, Ning J, Handy B, Wagar E, Meng Q. Combining prostate cancer antigen 3 (PCA3) and prostate-specific antigen (PSA) improves diagnostic accuracy in men at risk of prostate cancer. Presented at the American Association for Clinical Chemistry Annual Meeting, Philadelphia, Pennsylvania, 2016.
- Cao L, Maloy C, Munson S, Handy B, Wagar E, Meng Q. Performance evaluation of mycophenolic acid (MPA) on Siemens Dimension Xpand. Presented at the American Association for Clinical Chemistry Annual Meeting, Philadelphia, Pennsylvania, 2016.
- Chen M, Handy BC, Wagar EA, Meng Q. Laboratory investigation of spurious hyperkalemia. Presented at the American Association for Clinical Chemistry Annual Meeting, Chicago, Illinois. e-Pub 2014.
- Chen M, Handy BC, Wagar EA, Meng Q. Factual of fictitious hypocalcemia. Presented at the American Association for Clinical Chemistry Annual Meeting, Chicago, Illinois, 2014.
- Chen M, Handy BC, Wagar EA, Meng Q. Investigation on causes and impact of specimen rejection in the clinical chemistry laboratory. Presented at the American Association for Clinical Chemistry Annual Meeting, 2014.
- Sherman SI, Michaelis C, Gornet T, Handy B, Waguespack SG, Hu M, Busaidy N, Jimenez C, Cabanillas ME, Cote G.. Overall survival is reduced in patients with detectable circulating tumor cells from metastatic medullary thyroid cancer. Presented at the 83rd Annual Meeting of the American Thyroid Association, San Juan, Puerto Rico, 2013.
- Vernet MA, Apple F, Handy B, Venge P, Guo VY, Dufoix-Cusin S, Incaurgarat B, Hausmann M.. Clinical Performance of VIDAS Galectin-3: predictive value for mortality and hospitalization in a multinational trial in heart failure. Presented at the Annual Meeting of the Heart Failure Association of the European Society of Cardiology, Lisbon, Portugal, 2013.
Letters to the Editor
- Meng QH, Handy BC, Wagar E. Falsely elevated tacrolimus concentrations on the Dimension Xpand. Clinical Biochemistry 48: 1210, 2015.
- Meng QH, Handy B, Wagar EA. It's not easy being blue-green. Ann Lab Med 33: 457 - 458, 2013.
- Meng QH, Handy B, Wagar E. Confirmatory testing of urine ketones and bilirubin: still necessary?. Archives of Pathology and Laboratory Medicine 137: 1028 - 1029, 2013.
Patient Reviews
CV information above last modified March 22, 2018